Stephanie Ling

10PUBLICATIONS
24CO-AUTHORS
Toxicology (incl. clinical toxicology)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPharmacogenomicsRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.

Stephanie F Ling, Joshua L Bennett, Vanessa J Reid

|May 21, 2025
Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis.

S F Ling, P Ho, M Bukhari

|May 13, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.

Stephanie F Ling, Chuan Fu Yap, Nisha Nair

|Jun 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis.

Stephanie F Ling, Kayode Ogungbenro, Adam S Darwich

|Jun 30, 2023
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.

Stephanie F Ling, Chuan Fu Yap, Nisha Nair

|Jul 18, 2022
Vitamin D prescribing practices among clinical practitioners during the COVID-19 pandemic.

Edward B Jude, Nikolaos Tentolouris, Ashu Rastogi

Pageof 2

Frequent Collaborators

7 joint publications

Anne Barton

3 joint publications

Ann W Morgan

3 joint publications

Anthony G Wilson

3 joint publications

Kimme L Hyrich